SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  March 22, 2004

 

Specialty Laboratories, Inc.

(Exact name of registrant as specified in its charter)

 

California

(State or other jurisdiction of incorporation)

 

001-16217

 

95-2961036

(Commission File Number)

 

(IRS Employer Identification No.)

 

 

 

2211 Michigan Avenue,   Santa Monica, California

 

90404

Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (310) 828-6543

 

Not applicable

(Former name or former address, if changed since last report)

 

 



 

Item 5.  Other Events and Regulation FD Disclosure.

 

On March 22, 2004, Specialty Laboratories, Inc., (the “Registrant”) announced that Frank J. Spina, senior vice president and chief financial officer, left the Company effective March 19, 2004 to pursue other professional opportunities.

 

A copy of the press release issued by the Registrant on March 22, 2004 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.

 

Item 7.

 

Financial Statements and Exhibits

 

 

 

(c)

 

Exhibits

The following document is filed as an exhibit to this report:

 

 

 

 

 

 

99.1

Press Release dated March 22, 2004.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Specialty Laboratories, Inc. has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized, in the City of Santa Monica, State of California, on March 22, 2004.

 

 

SPECIALTY LABORATORIES, INC.

 

 

 

 

 

By:

/s/ Nicholas R. Simmons

 

 

 

Nicholas R. Simmons
General Counsel

 

3